The role of mass spectrometry in the "Omics" era

Current Organic Chemistry

Volumn 17, Issue 23, 2013, Pages 2891-2905

  Di Girolamo, Francesco ^a   Lante, Isabella ^b   Muraca, Maurizio ^a   Putignani, Lorenza ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SAN CAMILLO HOSPITAL   (Italy)

Author keywords

Mass spectrometry; Meta omics; MS; MS based genomics; MS based lipidomics; MS based metabolomics; MS based proteomics

Indexed keywords

CELL CULTURE; DATA HANDLING; DISEASE CONTROL; MASS SPECTROMETRY; MOLECULAR BIOLOGY; PROTEINS;

'OMICS'; GENOMICS; LIPIDOMICS; MASS SPECTROMETRY-BASED GENOMIC; MASS SPECTROMETRY-BASED LIPIDOMIC; MASS SPECTROMETRY-BASED METABOLOMIC; MASS SPECTROMETRY-BASED PROTEOMIC; META-OMIC; METABOLOMICS; PROTEOMICS;

GENOME;

EID: 84893200314     PISSN: 13852728     EISSN: None     Source Type: Journal    
DOI: 10.2174/1385272817888131118162725     Document Type: Review

References (171)

1. Chughtai, K. Heeren, R.M. Mass Spectrometric Imaging for biomedical tissue analysis. Chem. Rev., 2010, 110, 3237-3277.
2. Feng, X.; Liu, X.; Luo, Q.; Liu, B.F. Mass spectrometry in systems biology: an overview. Mass Spectrom. Rev., 2008, 27, 635-660.
3. Munson, M.S.B.; Field, F.H. Chemical ionization mass spectrometry. General introduction. J. Am. Chem. Soc., 1966, 88, 2621-2630.
4. Torgerson, D.F.; Skowronski, R.P.; Macfarlane, R.D. New approach to the mass spectroscopy of non-volatile compounds. Biochem. Biophys. Res. Comm., 1974, 60, 616-621.
5. Beckey, H.D. Field desorption mass spectrometry: A technique for the study of thermally unstable substances of low volatility. Int. J. Mass Spectrom. Ion Phys., 1969, 2, 500-503.
6. Inghram, M.G.; Gomer, R. Mass spectrometric analysis of ions from the field microscope. J. Chem. Phys., 1954, 22, 1279-1280.
7. Barber, M.; Bordoli, R.S.; Sedgwick, R.D.; Tyler, A. Fast atom bombardment of solids as an ion source in mass spectrometry. Nature, 1981, 293, 270-275.
8. Morris, H.R.; Panico, M.; Barber, M.; Bordoli, R.S.; Sedgwick, R.D.; Tyler, A. Fast atom bombardment: A new mass spectrometric method for peptide sequence analysis. Biochem. Biophys. Res. Comm., 1981, 101, 623-631.
9. Shackleton, C.H.; Straub, K.M. Direct analysis of steroid conjugates: The use of secondary ion mass spectrometry. Steroids, 1982, 40, 35-51.
10. Yamashita, M.; Fenn, J.B. Negative ion source production with electrospray ion source. J. Phys. Chem., 1984, 88, 4671-4675.
11. Hillenkamp, F.; Karas, M. Mass spectrometry of peptides and proteins by matrix-assisted ultraviolet laser desorption/ionization. Meth. Enzymol., 1990, 193, 280-295.
12. Hillenkamp, F.; Karas, M.; Beavis, R.C.; Chait, B.T. Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers. Anal. Chem., 1991, 63, 1193A-1203A.
13. Tanaka, K.; Waki, Y.; Ido, Y.; Akita, S.; Yoshida, Y.; Yoshida, T. Protein and polymer analyses up to m/z 100,000 by laser ionization time-of-flight mass spectrometry. Rapid. Comm. Mass Spectrom., 1988, 2, 151-153.
14. Karas, M.; Hillenkamp, F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 Daltons. Anal. Chem., 1988, 60, 2299-2301.
15. Kebarle, P. A brief over view of the present status of the mechanisms involved in electrospray mass spectrometry. J. Mass Spectrom., 2000, 35, 804-817.
16. Baldwin, M.A. Mass spectrometers for the analysis of biomolecules. Meth. Enzymol., 2005, 402, 3-48.
17. Dole, M.; Mach, L.; Hines, R.L.; Mobley, R.C.; Ferguson, L.D.; Alice, M.B. Molecular beams of macroions. J. Chem. Phys., 1968, 49, 2240-2247.
18. Griffiths, W.J.; Jonsson, A.P.; Liu, S.; Rai, D.K.; Wang, Y. Electrospray and tandem mass spectrometry in biochemistry. Biochem. J., 2001, 355, 545-561.
19. Emmett, M.R.; Caprioli, R.M. Micro electrospray mass spectrometry: Ultrahigh sensitivity analysis of peptides and proteins. J. Am. Chem. Soc. Mass Spectrom., 1994, 5, 605-613.
20. Gale, D.C.; Smith, R.D. Small volume and low flow-rate electrospray ionization mass spectrometry of aqueous samples. Rapid Comm. Mass Spectrom., 1993, 7, 1017-1021.
21. Karas, M.; Bahr, U.; Dulcks, T. Nano-electrospray ionization mass spectrometry: Addressing analytical problems beyond routine. Fresen. J. Anal. Chem., 2000, 366, 669-676.
22. Banoub, J.; Thibault, P.; Mansour, A.; Cohen, A.; Heeley, D.H.; Jackman, D. Characterisation of the intact rainbow trout vitellogenin protein and analysis of its derived tryptic and cyanogen bromide peptides by matrix-assisted laser desorption/ionisation time-of-flight-mass spectrometry and electrospray ionisation quadrupole/time-of-flight mass spectrometry. Eur. J. Mass Spectrom., 2003, 9, 509-524.
23. Banoub, J.; Cohen, A.; Mansour, A.; Thibault, P. Characterization and de novo sequencing of Atlantic salmon vitellogenin protein by electrospray tandem and matrix-assisted laser desorption/ionization mass spectrometry. Eur. J. Mass Spectrom., 2004, 10, 121-134.
24. Gut, I.G. DNA analysis by MALDI-TOF mass spectrometry. Hum. Mutat., 2004, 23, 437-441.
25. Balazy, M. Eicosanomics: Targeted lipidomics of eicosanoids in biological systems. Prostag. Other Lipid Mediat., 2004, 73, 173-180.
26. Harvey, D.J. Matrix-assisted laser desorption/ionization mass spectrometry of carbohydrates and glycoconjugates. Int. J. Mass Spectrom., 2003, 226, 1-35.
27. Karas, M.; Bachmann, D.; Hillenkamp, F. Influence of the wavelength in high irradiance ultraviolet laser desorption mass spectrometry of organic molecules. Anal. Chem., 1985, 57, 2935-2939.
28. Karas, M.; Bachmann, D.; Bahr, U.; Hillenkamp, F. Matrix-assisted ultraviolet-laser desorption of non volatile compounds. Int. J. Mass Spectrom. Ion Processes, 1987, 78, 53.
29. Strupat, K.; Karas, M.; Hillenkamp, F. 2,5-Dihidroxybenzoic acid: a new matrix for laser desorption-ionization mass spectrometry. Int. J. Mass Spectrom. Ion Processes, 1991, 111, 89-102.
30. Xiang, F.; Beavis, R.C. Growing protein-doped sinapic acid crystals for laser desorption: an alternative preparation method for difficult Samples. Org. Mass Spectrom., 1993, 28, 1424.
31. Allwood, D.; Dreyfus, R.; Perera, I.; Dyer, P. Optical absorption of matrix compounds for laser-induced desorption and ionization (MALDI). Appl. Surf. Sci., 1997, 109/110, 154-157.
32. Hillenkamp, F.; Karas, M.; Holtkamp, D.; Klusener, P. Energy deposition in ultraviolet laser desorption mass spectrometry of biomolecules. Int. J. Mass Spectrom. Ion Phys., 1986, 69, 265-276.
33. Chaurand, P.; Schwartz, S.A.; Reyzer, M.L.; Caprioli, R.M. Imaging mass spectrometry: principles and potentials. Toxicol. Pathol., 2005, 33, 92-101.
34. Hanrieder, J.; Ljungdahl, A.; Andersson, M. MALDI imaging mass spectrometry of neuropeptides in Parkinson's disease. J. Vis. Exp., 2012, 60.
35. Stoeckli, M.; Staab, D.; Schweitzer, A.; Gardiner, J.; Seebach, D. Imaging of a beta-peptide distribution in whole-body mice sections by MALDI mass spectrometry. J. Am. Soc. Mass Spectrom., 2007, 11, 1921-1924.
36. Cazares, L.H.; Troyer, D.A.; Wang, B.; Drake, R.R.; Semmes, O.J. MALDI tissue imaging: from biomarker discovery to clinical applications. Anal. Bioanal. Chem., 2011, 1, 17-27.
37. Pevsner, P.H.; Melamed, J.; Remsen, T.; Kogos, A.; Francois, F.; Kessler, P.; Stern, A.; Anand, S. Mass spectrometry MALDI imaging of colon cancer biomarkers: a new diagnostic paradigm. Biomark. Med., 2009, 1, 55-69.
38. Marko-Varga, G.; Fehniger, T.E.; Rezeli, M.; Döme, B.; Laurell, T.; Végvári, A. Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging. J. Proteomics, 2011, 7, 982-992.
39. Hsieh, Y.; Chen, J.; Korfmacher, W.A. Mapping pharmaceuticals in tissues using MALDI imaging mass spectrometry. J. Pharmacol. Toxicol. Methods, 2007, 2, 193-200.
40. Khatib-Shahidi, S.; Andersson, M.; Herman, J.L.; Gillespie, T.A.; Caprioli, R.M. Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry. Anal. Chem., 2006, 18, 6448-6456.
41. Reyzer, M.L.; Hsieh, Y.; Ng, K.; Korfmacher, W.A.; Caprioli, R.M. Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry. J. Mass Spectrom., 2003, 10, 1081-1092.
42. Hutchens, T.W.; Yip, T.T. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid. Commun. Mass Spectrom., 1993, 7, 576-580.
43. Issaq, H.J.; Veenstra, T.D.; Conrads, T.P.; Felschow, D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun., 2002, 292, 587-592.
44. Fung, E.T.; Thulasiraman, V.; Weinberger, S. R. Protein biochips for differential profiling. Curr. Opin. B, 2001, 1, 65-69.
45. Fung, E.T.; Enderwick, C. ProteinChip clinical proteomics: computational challenges and solutions. Biotechniques, Supplement, 2002, 32, S34-S41.
46. Paul, W.; Steinwedel, H. Ein neues massenspektrometer ohne magnetfeld. Zeitschrift für Naturforschung, 1953, 8, 448-450.
47. Paul W. Electromagnetic Traps for Charged and Neutral Particles (Nobel Lecture). Angew. Chem. Int. Ed., 1990, 29, 739-748.
48. Stephens, W.E. A Pulsed Mass Spectrometer with Time Dispersion. Phys. Rev., 1946, 69, 691.
49. Comisarow, M.B.; Marshall, A.G. Fourier transform ion cyclotron resonance spectroscopy. Chem. Phys. Lett., 1974, 25, 282-283.
50. Makarov, A. In: Practical Aspects of Trapped Ion Mass Spectrometry; R. E. March, J.F.J. Todd, Ed.; CRC Press (Taylor & Francis): New York, 2009; Vol. 4, pp. 251-272
51. Hjertén, S. Free zone electrophoresis. Chromatogr. Rev., 1967, 9, 122-219.
52. Ohnesorge, J.; Neusüß, C.; Wätzig H. Quantitation in capillary electrophoresis-mass spectrometry. Electrophoresis, 2005, 26, 3973-3987.
53. Mischak, H.; Coon, J.J.; Novak, J.; Weissinger, E.M.; Schanstra, J.P.; Dominiczak, A.F. Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrom. Rev. 2009, 28, 703-724.
54. Klampfl, C.; Buchberger W. Recent advances in the use of capillary electrophoresis coupled to high-resolution mass spectrometry for the analysis of small molecules. Curr. Anal. Chemistry, 2010, 6, 118-125.
55. Sniehotta, M.; Schiffer, E.; Zürbig, P.; Novak, J.; Mischak, H. CE-a multifunctional application for clinical diagnosis. Electrophoresis, 2007, 28, 1407-1417.
56. Schmitt-Kopplin, P.; Frommberger, M. Capillary electrophoresis-mass spectrometry: 15 years of developments and applications. Electrophoresis, 2003, 24, 3837-3867.
57. Marsh, A.; Broderick, M.; Altria, K.; Power, J.; Donegan, S.; Clark, B. Capillary electrophoresis for pharmaceutical analysis. Methods Mol. Biol., 2008, 384, 205-245.
58. Altria, K.; Marsh, A.; Griend, C.S. Capillary electrophoresis for the analysis of small-molecule pharmaceuticals. Electrophoresis, 2006, 27, 2263-2282.
59. James, A.T.; Martin, A.J.P. Gas-liquid partition chromatography; the separation and micro-estimation of volatile fatty acids from formic acid to dodecanoic acid. Biochem. J., 1952, 50, 679-690.
60. Vance, D.E.; Vance J.E. Biochemistry of Lipids, Lipoproteins and Membranes, 5th Ed.; Elsevier Science Publishers B.V.: Amsterdam, 2008.
61. Kishimoto, K.; Urade, R.; Ogawa, T.; Moriyama, T. Nondestructive quantification of neutral lipids by thin-layer chromatography and laser-fluorescent scanning: Suitable methods for "lipidome" analysis. Biochem. Biophys. Res. Commun., 2001, 281, 657-662.
62. Yetukuri, L; Katajamaa, M.; Medina-Gomez, G.; Seppanen-Laakso, T.; VidalPuig, A.; Oresic, M. Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis. BMC Syst. Biol., 2007, 1, 1-12.
63. Han, X.; Jiang, X. A review of lipidomic technologies applicable to sphingolipidomics and their relevant applications. Eur. J. Lipid. Sci. Technol., 2009, 111, 39-52.
64. Fahy, E.; Subramaniam, S.; Brown, H.A.; Glass, C.K.; Merrill, A.H.; Murphy, R.C.; Raetz, C.R.; Russell, D.W.; Seyama, Y.; Shaw, W.; Shimizu, T.; Spener, F.; van Meer, G.; Van Nieuwenhze, M.S.; White, S.H.; Witztum, J.L.; Dennis, E.A. A comprehensive classification system for lipids. J. Lipid. Res., 2005, 46, 839-861.
65. Yang, K.; Cheng, H.; Gross, R.W.; Han X. Automated lipid identification and quantification by multi-dimensional mass spectrometry based shotgun lipidomics. Anal. Chem., 2009, 81, 4356-4368.
66. Han, X.; Gross, R.W. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: A bridge to lipidomics. J. Lipid. Res., 2003, 44, 1071-1079.
67. Wenk, M.R. The emerging field of lipidomics. Nat. Rev. Drug Discov., 2005, 4, 594-610.
68. Dennis, E.A. Lipidomics joins the omics evolution. Proc. Natl. Acad. Sci. USA, 2009, 106, 2089-2090.
69. Griffiths, W.J.; Wang, Y. Mass spectrometry: From proteomics to metabolomics and lipidomics. Chem. Soc. Rev., 2009, 38, 1882-1896.
70. Gross, R.W.; Han, X. Lipidomics at the interface of structure and function in systems biology. Chem. Biol., 2011, 18, 284-291.
71. Wood, R.; Harlow, R.D. Structural studies of neutral glycerides and phosphoglycerides of rat liver. Arch. Biochem. Biophys. 1969, 131, 495-501.
72. Maffei Facino, R.; Carini, M.; Aldini, G.; Colombo, L.; Characterization of the intermediate products of lipid peroxidation in phosphatidylcholine liposomes by fast-atom bombardment mass spectrometry and tandem mass spectrometry techniques. Rapid Commun. Mass Spectrom., 1996, 10, 1148-1152.
73. Han, X.; Gubitosi-Klug, R.A.; Collins, B.J.; Gross, R.W. Alterations in individual molecular species of human platelet phospholipids during thrombin stimulation: electrospray ionization mass spectrometry-facilitated identification of the boundary conditions for the magnitude and selectivity of thrombin-induced platelet phospholipid hydrolysis. Biochemistry, 1996, 35, 5822-5832.
74. Han, X.; Abendschein, D.R.; Kelley, J.G.; Gross, R.W. Diabetes-induced changes in specific lipid molecular species in rat myocardium. Biochem. J., 2000, 352, 79-89.
75. Han, X.; Gross, R.W. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: A bridge to lipidomics. J. Lipid. Res., 2003, 44, 1071-1079.
76. Feng, L.; Prestwich, G. D. Functional Lipidomics. CRC Press (Taylor & Francis): New York, 2006.
77. Fenn J.B. Electrospray Wings for Molecular Elephants (Nobel Lecture). Angew. Chem. Int. Ed., 2003, 42, 3871-3894.
78. Tanaka, K. The origin of macromolecule ionization by laser irradiation (Nobel Lecture). Angew. Chem. Int. Ed., 2003, 42, 3860-3870.
79. Murphy, R.C.; Axelsen, P.H. Mass spectrometric analysis of long-chain lipids. Mass Spectrom. Rev., 2010, 30, 579-599.
80. Vigneau-Callahan, K.E.; Shestopalov, A.I.; Milbury, P.E.; Matson, W.R.; Kristal, B.S. Characterization of dietdependent metabolic serotypes: Analytical and biological variability issues in rats. J. Nutr., 2001, 131, 924S-932S.
81. Oliver, S.G.; Winson, M.K.; Kell, D.B.; Baganz, F. Systematic functional analysis of the yeast genome. Trends Biotechnol., 1998, 9, 373-378.
82. Beecher, C.W.W. In: Metabolic profiling: Its role in biomarker discovery and gene function analysis; Harrigan, G.G.; Goodacre, R., Ed.; Springer, 2003; Vol. 17, pp 311-319.
83. Dettmer, K.; Hammock, B.D. Metabolomics-A new exciting field within the "omics" sciences. Environ. Health Perspect., 2004, 112, A396-397.
84. Fiehn, O. Metabolomics-The link between genotypes and phenotypes. Plant Mol. Biol., 2002, 48, 155-171.
85. Hopfgartner, G.; Tonoli, D.; Varesio, E. High-resolution mass spectrometry for integrated qualitative and quantitative analysis of pharmaceuticals in biological matrices. Anal. Bioanal. Chem., 2012, 8, 2587-2596.
86. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature, 2004, 431, 931-945.
87. Schurch, S.; Bernal-Mendez, E.; Leumann, C.J. Electrospray tandem mass spectrometry of mixed-sequence RNA/DNA oligonucleotides. J. Am. Soc. Mass Spectrom., 2002, 13, 936-945.
88. Hong, I.S.; Carter, K.N.; Sato, K.; Greenberg, M.M. Characterization and mechanism of formation of tandem lesions in DNA by a nucleobase peroxyl radical. J. Am. Chem. Soc., 2007, 129, 4089-4098.
89. Thompson, A.; Prescott, M.; Chelebi, N.; Smith, J.; Brown, T.; Schmidt, G. Electrospray ionisation-cleavable tandem nucleic acid mass tag-peptide nucleic acid conjugates: synthesis and applications to quantitative genomic analysis using electrospray ionisation-MS/MS. Nucleic Acids Res., 2007, 4, 28.
90. Li, Y.; Tang, K.; Little, D.P.; Koster, H.; Hunter, R.L.; McIver, R.T. High resolution MALDI Fourier transform mass spectrometry of oligonucleotides. Anal. Chem., 1996, 68, 2090-2096.
91. Hettich, R.L. Formation and characterization of iron-oligonucleotide complexes with matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry. J. Am. Soc. Mass Spectrom., 1999, 10, 941-949.
92. Hettich, R.L. Investigating the effect of transition metal ion oxidation state on oligodeoxyribonucleotide binding by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry. Int. J. Mass Spectrom., 2001, 204, 55-75.
93. Muddiman, D.C.; Smith, R.D. Sequencing and characterization of larger oligonucleotides by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. Rev. Anal. Chem., 1998, 17, 1-68.
94. Hofstadler, S.A.; Sannes-Lowery, K.A.; Hannis, J.C. Analysis of nucleic acids by FTICR MS. Mass Spectrom. Rev., 2005, 24, 265-285.
95. Null, A.P.; Hannis, J.C.; Muddiman, D.C. Genotyping of simple and compound short tandem repeat loci using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. Anal. Chem., 2001, 73, 4514-4521.
96. Lau, C.C.; Yue, P.Y.K, Chui, S.H.; Chui, A.K.K.; Yam, W.C.; Wong, R.N.S. Detection of single nucleotide polymorphisms in hepatitis B virus precore/basal core promoter region by matrix-assisted laser des orption/ ionization time-of-flight mass spectrometry. Anal. Biochem., 2007, 366, 93-95.
97. Misra, A.; Hong, J.Y.; Kim, S. Multiplex genotyping of cytochrome P450 single-nucleotide polymorphisms by use of MALDI-TOF mass spectrometry. Clin. Chem., 2007, 53, 933-939.
98. Schena, M.; Shalon, D.; Davis, R.W.; Brown, P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science, 1995, 270, 467-470.
99. Wu, L.; Hwang, S.L.; Rezaul, K.; Lu, L.J.; Mayya, V.; Gerstein, M.; Eng, J.K.; Lundgren, D.H.; Han, D.K. Global survey of human T leukemic cells by integrating proteomics and transcriptomics profiling. Mol. Cell. Proteomics, 2007, 6, 1343-1353.
100. Van Duy, N.; Wolf, C.; Mader, U.; Lalk, M.; Langer, P.; Lindequist, U.; Hecker, M.; Antelmann, H. Transcriptome and proteome analyses in response to 2-methylhydroquinone and 6-brom-2-vinyl-chroman-4-on reveal different degradation systems involved in the catabolism of aromatic compounds in Bacillus subtilis. Proteomics, 2007, 7, 1391-1408.
101. Schmidt, M.W.; Houseman, A.; Ivanov, A.R.; Wolf, D.A. Comparative proteomic and transcriptomic profiling of the fission yeast Schizosaccharomyces pombe. Mol. Syst. Biol., 2007, 3, 79.
102. Evans, V.C.; Barker, G.; Heesom, K.J.; Fan, J.; Bessant, C.; Matthews, D.A. De novo derivation of proteomes from transcriptomes for transcript and protein identification. Nat. Methods., 2012, 12, 1207-1211.
103. Reinhardt, C. Shifting And Rearranging: Physical Methods And the Transformation of Modern Chemistry. Science History Publications: Sagamore Beach, 2006.
104. Fenn J. B.; Mann M.; Meng, C. K.; Wong, S. F.; Whitehouse, C. M.; Science, 1989, 246, 64-71.
105. Mann, M.; Wilm, M.; Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal. Chem., 1994, 66, 4390-4399.
106. Aebersold, R.; Mann, M. Mass spectrometry-based proteomics. Nature. 2003, 6928, 198-207.
107. Wolters, D.A.; Washburn, M.P.; Yates, J.R. An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem., 2001, 23, 5683-90.
108. Gatlin, C.L.; Eng, J.K.; Cross, S.T.; Detter, J.C.; Yates, J.R.III; Automated identification of amino acid sequence variations in proteins by HPLC/microspray tandem mass spectrometry, Anal. Chem., 2000, 4, 757-763.
109. Elias, J.E.; Gygi, S.P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods, 2007, 4, 207-214.
110. Zhang, Y.; Zhang, Y.; Adachi, J.; Olsen, J.V.; Shi, R.; de Souza, G.; Pasini, E.; Foster, L.J.; Macek, B.; Zougman, A.; Kumar, C.; Wisniewski, J.R.; Jun W.; Mann, M. MAPU: Max-Planck Unified database of organellar, cellular, tissue and body fluid proteomes. Nucleic Acids Res., 2007, 35 (Database issue), D771-779.
111. Bell, A.W.; Nilsson, T.; Kearney R.E.; Bergeron, J.J. The protein microscope: incorporating mass spectrometry into cell biology. Nat. Methods, 2007, 4, 783-784.
112. Lane, C.S.; Wang, Y.; Betts, R.; Griffiths, W.J.; Patterson, L.H. Comparative cytochrome P450 proteomics in the livers of immunodeficient mice using 18O stable isotope labeling. Mol. Cell. Proteomics, 2007, 6, 953-962.
113. Fang, X.; Zhang, W.W. Affinity separation and enrichment methods in proteomic analysis. J. Proteomics, 2008, 71, 284-303.
114. Boschetti, E.; Righetti, P.G. The art of observing rare protein species in proteomes with peptide ligand libraries. Proteomics 9, 2009, 1492-1510.
115. Issaq, H.J.; Veenstra, T.D.; Conrads, T.P.; Felschow, D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun., 2002, 292, 587-592.
116. Lin, C.Y.; Tsui, K.H.; Yu, C. C.; Yeh, C.W.; Chang, P.L.; Yung, B.Y.M. Searching cell-secreted proteomes for potential urinary bladder tumor markers. Proteomics, 2006, 6, 4381-4389.
117. Petricoin, E.F.; Ardekani, A.M.; Hitt, B.A.; Levine, P.J.; Fusaro, V.A.; Steinberg, S.M.; Mills, G.B.; Simone, C.; Fishman, D.A.; Kohn, E.C.; Liotta, L.A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 2002, 359, 572-577.
118. Petricoin, E.F.; Liotta, L.A. Mass spectrometry-based diagnostics: the upcoming revolution in disease detection, Clin. Chemistry, 2003, 49, 533-534.
119. Cadron, I.; Van Gorp, T.; Amant F.; Vergote, I.; Moerman, P.; Waelkens, E.; Daemen, A.; Van De Plas, R.; De Moor, B.; Zeillinger, R. The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles. Anticancer Res., 2009, 29, 1039-1046.
120. Zhu, Y.; Wu, R.; Sangha N.; Yoo, C.; Cho, K.R.; Shedden, K.A.; Katabuchi, H.; Lubman, D.M. Classifications of ovarian cancer tissues by proteomic patterns. Proteomics, 2006, 6, 5846-5856.
121. Lumachi F.; Basso, S.M.M. Serum tumor markers in patients with breast cancer. Exp. Rev. of Anticancer Ther., 2004, 4, 921-931.
122. Safi, F.; Kohler, I.; Rottinger, E.; Beger, H.G. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer: a comparative study with carcinoembryonic antigen. Cancer, 1991, 68, 574-582.
123. Zhang, J. Li; Rosenzweig, J.; Wang, Y.Y.; Chan, D.W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem., 2002, 48, 1296-1304.
124. Celis, J.E.; Gromov, P.; Cabezon, T.; Moreira, J.M.; Ambartsumian, N.; Sandelin, K.; Rank, F.; Gromova, I. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment. Mol. Cel. Proteomics, 2004, 3, 327-344.
125. Zeidan, B.A.; Townsend, P.A. SELDI-TOF proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression. Breast Cancer Res., 2008, 10, 107.
126. De Visschere, P.; Oosterlinck, W.; De Meerleer, G.; Villeirs, G. Clinical and imaging tools in the early diagnosis of prostate cancer, a review. JBR-BTR, 2010, 93, 62-70.
127. Humphrey P.A.; Andriole, G.L. Prostate cancer diagnosis. Missouri Medicine, 2010, 107, 107-112.
128. Roddam, A.W.; Duffy, M.J.; Hamdy F.C.; Ward, A.M.; Patnick, J.; Price, C.P.; Rimmer, J.; Sturgeon, C.; White, P.; Allen, N.E. Use of prostatespecific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis. Eur. Urology, 2005, 48, 3, 386-399.
129. Calvano, C.D.; Aresta, A.; Iacovone M.; De Benedetto, G.E.; Zambonin, C.G.; Battaglia, M.; Ditonno, P.; Rutigliano, M.; Bettocchi, C. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles. J. Pharm. Biomed. Analysis, 2010, 51, 907-914.
130. Zhou, M.; Prieto, D.A.; Lucas D.A.; Chan, K.C.; Issaq, H.J.; Veenstra, T.D.; Conrads, T.P. Identification of the SELDI ProteinChip human serum retentate by microcapillary liquid chromatography-tandem mass spectrometry, J. Proteome Res., 2006, 5, 2207-2216.
131. Li, J.N.; White, Z.; Zhang, Rosenzweig, J.; Mangold, L.A.; Partin, A.W.; Chan, D.W. Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population, J. Urology, 2004, 171, 1782-1787.
132. Lee, N.P.; Chen, L.; Lin M.C.; Tsang, F.H.; Yeung, C.; Poon, R.T.; Peng, J.; Leng, X.; Beretta, L.; Sun, S.; Day, P.J.; Luk, J.M. Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma. J. Proteome Res., 2009, 8, 1293-1303.
133. Zinkin, N.T.; Grall, F.; Bhaskar, K.; Out, H.H.; Spentzos, D.; Kalmowitz, B.; Wells, M.; Guerrero, M.; Asara, J.M.; Libermann, T.A.; Afdhal, N.H. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin. Cancer Res., 2008, 14, 470-477.
134. Corona, G.; De Lorenzo, E.; Elia C.; Simula, M.P.; Avellini, C.; Baccarani, U.; Lupo, F.; Tiribelli, C.; Colombatti, A.; Toffoli, G. Differential proteomic analysis of hepatocellular carcinoma. Int. J. Oncology, 2010, 36, 93-99.
135. Tang, Z.; Varghese, R.S.; Bekesova, S.; Loffredo, C.A.; Hamid, M.A.; Kyselova, Z.; Mechref, Y.; Novotny, M.V.; Goldman, R.; Ressom, H.W. Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. J. Proteome Res., 2010, 9, 104-112.
136. Liu, M.; Li, C.F.; Chen, H.S.; Lin, L.Q.; Zhang, C.P.; Zhao, J.L.; Liu, Y.; Zhang, S.J.; Jin, J.C.; Wang, L.; Liu, J.R. Differential expression of proteomics models of colorectal cancer, colorectal benign disease and healthy controls. Proteome Sci., 2010, 8, 1-6.
137. Liu, W.; Gao, X.; Cai Q.; Li, J.; Zhu, Z.; Li, C.; Yao, X.; Yang, Q.; Xiang, M.; Yan, M.; Zhu, Z. Identification of novel serum biomarkers for gastric cancer by magnetic bead. Front. Biosci., 2010, 2, 961-971.
138. Gygi, S.P.; Rist, B.; Gerber, S.A.; Turecek, F.; Gelb M.H.; Aebersold, R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol., 1999, 17, 994-999.
139. Ross, P.L.; Huang, Y.N.; Marchese, J.N.; Williamson, B.; Parker, K.; Hattan, S.; Khainovski, N.; Pillai, S.; Dey, S.; Daniels, S.; Purkayastha, S.; Juhasz, P.; Martin, S.; Bartlet-Jones, M.; He, F.; Jacobson A.; Pappin, D.J. Multiplexed protein quantitation in Saccharomyces cerevisiae using aminereactive isobaric tagging reagents. Mol. Cell. Proteomics, 2004, 3, 1154-1169.
140. Ong, S.E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D.B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics, 2002, 5, 376-86.
141. Picotti, P.; Aebersold, R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat. Methods, 2012, 30, 555-566.
142. Gillet, L.C.; Navarro, P.; Tate, S.; Röst, H.; Selevsek, N.; Reiter, L.; Bonner, R.; Aebersold, R. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics, 2012, 11, 16700-16717.
143. Brun, V.; Masselon, C.; Garin, J.; Dupuis, A. Isotope dilution strategies for absolute quantitative proteomics. J. Proteomics, 2009, 72, 740-749.
144. Kirkpatrick, D.S.; Gerber, S.A.; Gygi, S.P. The absolute quantification strategy: a general procedure for the quantification of proteins and posttranslational modifications. Methods, 2005, 35, 265-273.
145. Zhang, G.; Ueberheide, B.M.; Waldemarson, S.; Myung, S.; Molloy, K.; Eriksson, J.; Chait, B.T.; Neubert, T.A.; Fenyö, D. Protein quantitation using mass spectrometry. Methods Mol. Biol., 2010, 673, 211-222.
146. Reid, G.E.; McLuckey S.A. Top down' protein characterization via tandem mass spectrometry. J. Mass Spectrom., 2002, 37, 663-675.
147. Wilmes, P.; Bond, P.L. The application of two-dimensional polyacrylamide gel electrophoresis and downstream analyses to a mixed community of prokaryotic microorganisms. Environ. Microbiol., 2004, 6, 911-920.
148. nd; Shah, M.; Hettich, R.L.; Banfield, J.F. Community proteomics of a natural microbial biofilm. Science, 2005, 5730, 1915-1920.
149. Denef, V.J.; VerBerkmoes, N.C.; Shah, M.B.; Abraham, P.; Lefsrud, M.; Hettich, R.L.; Banfield, J.F. Proteomics-inferred genome typing (PIGT) demonstrates inter-population recombination as a strategy for environmental adaptation. Environ. Microbiol., 2009, 11, 313-325.
150. Goltsman, D.S.; Denef, V.J.; Singer, S.W.; VerBerkmoes, N.C.; Lefsrud, M.; Mueller, R.S.; Dick, G.J.; Sun, C.L.; Wheeler, K.E.; Zemla, A.; Baker, B.J.; Hauser, L.; Land, M.; Shah, M.B.; Thelen, M.P.; Hettich, R.L.; Banfield, J.F. Community genomic and proteomic analyses of chemoautotrophic ironoxidizing Leptospirillum rubarum (Group II) and Leptospirillum ferrodiazotrophum (Group III) bacteria in acid mine drainage biofilms. Appl. Environ. Microbiol., 2009, 13, 4599-4615.
151. Lo, I.; Denef, V.J.; Verberkmoes, N.C.; Shah, M.B.; Goltsman, D.; DiBartolo, G.; Tyson, G.W.; Allen, E.E.; Ram, R.J.; Detter, J.C.; Richardson, P.; Thelen, M.P.; Hettich, R.L.; Banfield, J.F. Strain-resolved community proteomics reveals recombining genomes of acidophilic bacteria. Nature, 2007, 7135, 537-541.
152. Lacerda, C.M.; Choe, L.H.; Reardon, K.F. Metaproteomic analysis of a bacterial community response to cadmium exposure. J. Proteome Res., 2007, 6, 1145-1152.
153. Delmotte, N.; Knief, C.; Chaffron, S.; Innerebner, G.; Roschitzki, B.; Schlapbach, R.; von Mering, C.; Vorholt, J.A. Community proteogenomics reveals insights into the physiology of phyllosphere bacteria. Proc. Natl. Acad. Sci. U S A., 2009, 38, 16428-16433.
154. Park, C.; Helm, R.F. Application of metaproteomic analysis for studying extracellular polymeric substances (EPS) in activated sludge flocs and their fate in sludge digestion. Water Sci. Technol., 2008, 57, 2009-2015.
155. Wilmes, P.; Andersson, A.F.; Lefsrud, M.G.; Wexler, M.; Shah, M.; Zhang, B.; Hettich, R.L.; Bond, P.L.; VerBerkmoes, N.C.; Banfield, J.F. Community proteogenomics highlights microbial strain-variant protein expression within activated sludge performing enhanced biological phosphorus removal. ISME J., 2008, 8, 853-864.
156. Wilmes, P.; Wexler, M.; Bond, P.L. Metaproteomics provides functional insight into activated sludge wastewater treatment. PLoS One, 2008, 3, e1778.
157. Warnecke, F.; Luginbühl, P.; Ivanova, N.; Ghassemian, M.; Richardson, T.H.; Stege, J.T.; Cayouette, M.; McHardy, A.C.; Djordjevic, G.; Aboushadi, N.; Sorek, R.; Tringe, S.G.; Podar, M.; Martin, H.G.; Kunin, V.; Dalevi, D.; Madejska, J.; Kirton, E.; Platt, D.; Szeto, E.; Salamov, A.; Barry, K.; Mikhailova, N.; Kyrpides, N.C.; Matson, E.G.; Ottesen, E.A.; Zhang, X.; Hernández, M.; Murillo, C.; Acosta, L.G.; Rigoutsos, I.; Tamayo, G.; Green, B.D.; Chang, C.; Rubin, E.M.; Mathur, E.J.; Robertson, D.E.; Hugenholtz, P.; Leadbetter, J.R. Metagenomic and functional analysis of hindgut microbiota of a wood-feeding higher termite. Nature, 2007, 7169, 560-565.
158. Hongoh, Y. Toward the functional analysis of uncultivable, symbiotic microorganisms in the termite gut. Cell. Mol. Life Sci., 2011, 8, 1311-1325.
159. Toyoda, A.; Iio, W.; Mitsumori, M.; Minato, H. Isolation and identification of cellulose-binding proteins from sheep rumen contents. Appl. Environ. Microbiol., 2009, 75, 1667-1673.
160. Rudney, J.D.; Xie, H.; Rhodus, N.L.; Ondrey, F.G.; Griffin, T.J. A metaproteomic analysis of the human salivary microbiota by three-dimensional peptide fractionation and tandem mass spectrometry. Mol. Oral Microbiol., 2010, 25, 38-49.
161. Fouts, D.E.; Pieper, R.; Szpakowski, S.; Pohl, H.; Knoblach, S.; Suh, M.J.; Huang, S.T.; Ljungberg, I.; Sprague, B.M.; Lucas, S.K.; Torralba, M.; Nelson, K.E.; Groah, S.L. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J. Transl. Med., 2012, 10, 174.
162. Kan, J.; Hanson, T.E.; Ginter J.M.; Wang, K.; Chen, F. Metaproteomic analysis of Chesapeake Bay microbial communities. Saline Syst., 2005, 1, 7.
163. Sowell, S.M.; Wilhelm, L.J.; Norbeck, A.D.; Lipton, M.S.; Nicora, C.D.; Barofsky, D.F.; Carlson, C.A.; Smith, R.D.; Giovanonni, S.J. Transport functions dominate the SAR11 metaproteome at low-nutrient extremes in the Sargasso Sea. ISME J., 2009, 1, 93-105.
164. leiner, M.; Wentrup, C.; Lott, C.; Teeling, H.; Wetzel, S.; Young, J.; Chang, Y.J.; Shah, M.; VerBerkmoes, N.C.; Zarzycki, J.; Fuchs, G.; Markert, S.; Hempel, K.; Voigt, B.; Becher, D.; Liebeke, M.; Lalk, M.; Albrecht, D.; Hecker, M.; Schweder, T.; Dubilier, N. Metaproteomics of a gutless marine worm and its symbiotic microbial community reveal unusual pathways for carbon and energy use. Proc. Natl. Acad. Sci. U S A., 2012, 19, E1173-1182.
165. Schulze, W.X.; Gleixner, G.; Kaiser, K.; Guggenberger, G.; Mann, M.; Schulze, E.D. A proteomic fingerprint of dissolved organic carbon and of soil particles. Oecologia, 2005, 3, 335-343.
166. Klaassens, E.S.; de Vos, W.M.; Vaughan E.E. Metaproteomics approach to study the functionality of the microbiota in the human infant gastrointestinal tract. Appl. Environ. Microbiol., 2007, 73, 1388-1392.
167. Kolmeder, C.A.; de Been, M.; Nikkilä, J.; Ritamo, I.; Mättö, J.; Valmu, L.; Salojärvi, J.; Palva, A.; Salonen, A.; de Vos, W.M. Comparative metaproteomics and diversity analysis of human intestinal microbiota testifies for its temporal stability and expression of core functions. PLoS One, 2012, 1, e29913.
168. Verberkmoes, N.C.; Russell, A.L.; Shah, M.; Godzik, A.; Rosenquist, M.; Halfvarson, J.; Lefsrud, M.G.; Apajalahti, J.; Tysk, C.; Hettich, R.L.; Jansson, J.K. Shotgun metaproteomics of the human distal gut microbiota. ISME J., 2009, 2, 179-189.
169. Erickson, A.R.; Cantarel, B.L.; Lamendella, R.; Darzi, Y.; Mongodin, E.F.; Pan, C.; Shah, M.; Halfvarson, J.; Tysk, C.; Henrissat, B.; Raes, J.; Verberkmoes, N.C.; Fraser, C.M.; Hettich, R.L.; Jansson, J.K. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS One., 2012, 11, e49138.
170. Schneider, T.; Riedel, K. Environmental proteomics: analysis of structure and function of microbial communities. Proteomics, 2010, 10, 785-798.
171. Haange, S.B.; Oberbach, A.; Schlichting, N.; Hugenholtz, F.; Smidt, H.; von Bergen, M.; Till, H.; Seifert, J. Metaproteome analysis and molecular genetics of rat intestinal microbiota reveals section and localization resolved species distribution and enzymatic functionalities. J. Proteome Res., 2012, 11, 5406-5417.